RNALonza and Oxford Nanopore collaborate to advance mRNA TherapeuticsLatest NewsTo improve mRNA product analysis, the Lonza Group Ltd. and Oxford Nanopore Technologies plc. are working together to develop and market a test to assess multiple critical quality attributes of mRNA products Read more 31 January 2024 https://european-biotechnology.com/wp-content/uploads/2024/04/RS4669_iStock-1301531637.jpg 1080 1920 Margarita Milidakis /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Margarita Milidakis2024-01-31 11:30:202024-07-08 13:59:08Lonza and Oxford Nanopore collaborate to advance mRNA Therapeutics